Actual Medicinal Product (AMP) Stalevo 50mg/12.5mg/200mg tablets (Orion Pharma (UK) Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
No special precautions for storage.
- Provenance
-
This compatibility recommendation is derived from all strenghts of Stanek tablets (Teva UK Ltd) and Stalevo tablets (Orion Pharma (UK) Ltd).
- Generic
- Levodopa + Carbidopa + Entacapone
- Formulation
- Levodopa 50mg / Carbidopa 12.5mg / Entacapone 200mg tablets
-
Levodopa + Carbidopa + Entacapone
-
Levodopa 50mg / Carbidopa 12.5mg / Entacapone 200mg tablets
-
Stalevo 50mg/12.5mg/200mg tablets (Orion Pharma (UK) Ltd)
-
-